Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?
Elena Carboni, Anna R. Carta, Ezio Carboni
Topics & Concepts
PioglitazoneMedicineInsulin resistanceDiabetes mellitusRosiglitazoneDiseaseType 2 diabetesPandemicIntensive care medicineMetabolic syndromeInternal medicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)EndocrinologyCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders